|
Salvage
treatment for local recurrence after breast-conserving surgery
and radiation as initial treatment for mammographically detected
ductal carcinoma in situ of the breast.
Solin
LJ, Fourquet A, Vicini FA, et al. Cancer.
2001;91:1090-7.
Relationship
between excision volume, margin status, and tumor size with
the development of local recurrence in patients with ductal
carcinoma-in-situ treated with breast-conserving therapy.
Vicini
FA, Kestin LL, Goldstein NS, Baglan KL, Pettinga JE, Martinez
AA. J Surg Oncol. 2001;76:245-54.
Risk
factors for subsequent invasive breast cancer and breast cancer
death after ductal carcinoma in situ: a population-based case-control
study in sweden.
Warnberg
F, Bergh J, Zack M, Holmberg L. Cancer Epidemiol Biomarkers
Prev. 2001;10:495-9.
Histological
type and marker expression of the primary tumour compared
with its local recurrence after breast-conserving therapy
for ductal carcinoma in situ.
Bijker
N, Peterse JL, Duchateau L, et al. British Journal of Cancer. 84(4):539-544, 2001 Feb.
Extent
of excision margin width required in breast conserving surgery
for ductal carcinoma in situ.
Chan
KC, Knox WF, Sinha G, et al..
Cancer Cytopathology. 91(1):9-16, 2001 Jan 1.
Electrical
impedance scanning: a new technique in the diagnosis of lymph
nodes in which malignancy is suspected on ultrasound.
Malich
A, Fritsch T, Mauch C, et al. British
Journal of Radiology. 74(877):42-47, 2001 Jan.
Advanced
breast biopsy instrumentation for the evaluation of impalpable
lesions: A reliable diagnostic tool with little therapeutic
potential.
Marti
WR, Zuber M, Oertli D, et al. European
Journal of Surgery. 167(1):15-18, 2001 Jan.
Risk
factors for recurrence and metastasis after breast-conserving
therapy for ductal carcinoma-in-situ: analysis of European
Organization for Research and Treatment of Cancer Trial 10853.
Bijker
N, Peterse JL, Duchateau L, et al. J Clin Oncol. 2001;19:2263-71.
|
